To evaluate the kinetics of microbial engraftment following encapsulated oral microbiota transplant therapy (MTT) in patients with ulcerative colitis (UC) and to understand its significance for treatment outcomes.
Key Findings:
Engraftment at week 12 was significantly higher in the MTT group compared to the placebo group, indicating the effectiveness of MTT.
Baseline Shannon and Chao1 indices negatively correlated with week 12 donor engraftment in the MTT group, suggesting that initial microbiota diversity may influence treatment success.
SourceTracker engraftment positively correlated with week 12 distance from donors in treated patients, highlighting the dynamics of microbial integration.
Interpretation:
The study demonstrates that SourceTracker is an effective method for quantifying donor microbial community engraftment in UC patients, revealing distinct patterns of microbiota repopulation compared to other conditions like rCDI, which may inform future therapeutic strategies.
Limitations:
Small sample size with only 27 patients, which may limit the generalizability of the findings.
Limited follow-up data due to insufficient follow-up from some participants, potentially affecting the robustness of the conclusions.
Conclusion:
The findings suggest that MTT can lead to significant engraftment of donor microbiota in UC patients, with implications for donor selection and treatment protocols, and highlight the need for further research to optimize MTT strategies.
by Daphne Moutsoglou, Aneesh Syal, Sharon Lopez, Elizabeth C Nelson, Lulu Chen, Amanda J Kabage, Monika Fischer, Alexander Khoruts, Byron P Vaughn, Christopher Staley
